COVID-19 vaccine brings protection and, for some, uncomfortable side effects
Liz Hosp of Atlanta went to a drive-thru vaccine clinic back in January, getting her first dose of the Moderna vaccine with her husband Mike and with her mom, Anne Sayre, who had just moved into their Edgewood home in December.
Liz Hosp of Atlanta went to a drive-thru vaccine clinic back in January, getting her first dose of the Moderna vaccine with her husband Mike and with her mom, Anne Sayre, who had just moved into their Edgewood home in December.
Mercedes-Benz Stadium sets new COVID-19 shot record
A new record was set at Mercedes-Benz Stadium on Wednesday for the number of COVID-19 vaccines administered in a single day.
A new record was set at Mercedes-Benz Stadium on Wednesday for the number of COVID-19 vaccines administered in a single day.
Woman with advanced breast cancer gets COVID-19 vaccine after weighing benefits, risks
A Georgia woman diagnosed with advanced breast cancer says she was worried about getting the COVID-19 vaccine after learning of potential risks.
A Georgia woman diagnosed with advanced breast cancer says she was worried about getting the COVID-19 vaccine after learning of potential risks.
Republican lawmakers with medical degrees release video urging Americans to get COVID-19 vaccine
The group of lawmakers, which include doctors, dentists and registered pharmacists, encouraged supporters to get a COVID-19 vaccine in a new video.
The group of lawmakers, which include doctors, dentists and registered pharmacists, encouraged supporters to get a COVID-19 vaccine in a new video.
Health care providers, tech companies expand digital access to vaccine records
Technology companies and health care providers have developed digital vaccination records that you can access on your phone. The companies are explicit that these are not "vaccine passports," which have been linked to hot-button political debates.
Technology companies and health care providers have developed digital vaccination records that you can access on your phone. The companies are explicit that these are not "vaccine passports," which have been linked to hot-button political debates.
Pfizer, Moderna COVID-19 vaccines 94% effective at cutting hospitalizations for older adults, CDC says
The CDC’s study found the shots are 94% effective at preventing hospitalizations for fully vaccinated adults and 64% effective among partially vaccinated adults 65 and older.
The CDC’s study found the shots are 94% effective at preventing hospitalizations for fully vaccinated adults and 64% effective among partially vaccinated adults 65 and older.
Experts say COVID-19 vaccine for children ages 12-15 could be available by early May
Right now COVID19 vaccines are approved for kids ages 16 and older but researchers say the Pfizer vaccine could be available to children ages 12 to 15 by early May.
Right now COVID19 vaccines are approved for kids ages 16 and older but researchers say the Pfizer vaccine could be available to children ages 12 to 15 by early May.
Descendants of syphilis experiment at Tuskegee caution using study as reason not to get COVID vaccine
Descendants of the infamous syphilis experiment at Tuskegee are encouraging Black people to get the vaccine despite many Black people citing the experiment as a reason why they do not trust doctors or the vaccine.
Descendants of the infamous syphilis experiment at Tuskegee are encouraging Black people to get the vaccine despite many Black people citing the experiment as a reason why they do not trust doctors or the vaccine.
Pfizer CEO says oral antiviral pill to treat COVID-19 could be ready by end of year
Pfizer CEO Albert Bourla said a drug the company is testing to treat COVID-19 showed promising signs and could be available to the public by the end of this year.
Pfizer CEO Albert Bourla said a drug the company is testing to treat COVID-19 showed promising signs and could be available to the public by the end of this year.
Millions of Americans are missing ‘critical’ second COVID-19 vaccine shot, according to CDC data
The CDC says about 8% of Americans - or about 5 million people - are missing their second dose of the COVID-19 vaccine within the recommended timeframe.
The CDC says about 8% of Americans - or about 5 million people - are missing their second dose of the COVID-19 vaccine within the recommended timeframe.
Florida private school says it will not employ teachers who get the COVID-19 vaccine
A private school founded by an anti-vaccination activist in South Florida has warned teachers and staff against taking the COVID-19 vaccine, saying it will not employ anyone who has received the shot.
A private school founded by an anti-vaccination activist in South Florida has warned teachers and staff against taking the COVID-19 vaccine, saying it will not employ anyone who has received the shot.
Prince Harry and Meghan to lead 'Vax Live' world fundraising concert
The couple will serve as the campaign chairs of an effort to deliver COVID-19 vaccines to medical workers in the world’s poorest countries, which includes a fundraising concert in May.
The couple will serve as the campaign chairs of an effort to deliver COVID-19 vaccines to medical workers in the world’s poorest countries, which includes a fundraising concert in May.
Georgia's mass vaccination sites to shift to Johnson & Johnson shots in May
Georgia’s eight mass vaccination sites will start to phase out the use of the Pfizer vaccine starting at the end of the month, according to Gov. Brian Kemp.
Georgia’s eight mass vaccination sites will start to phase out the use of the Pfizer vaccine starting at the end of the month, according to Gov. Brian Kemp.
Georgia to lift pause on Johnson & Johnson COVID-19 vaccine
The Georgia Department of Public Health said Monday it will lift the statewide pause on administering the Johnson & Johnson COVID-19 vaccine after pausing over safety concerns.
The Georgia Department of Public Health said Monday it will lift the statewide pause on administering the Johnson & Johnson COVID-19 vaccine after pausing over safety concerns.
NIH to study COVID-19 vaccine effectiveness on patients with compromised immune systems
The National Institutes of Health is launching a study to better understand how COVID-19 vaccines impact patients with weakened immune systems, since vaccines typically require a healthy working immune system to fight a virus.
The National Institutes of Health is launching a study to better understand how COVID-19 vaccines impact patients with weakened immune systems, since vaccines typically require a healthy working immune system to fight a virus.
UCSF confirms man experienced blood clots after receiving Johnson & Johnson vaccine
A patient with blood clots at UCSF is the first case in which a male patient is experiencing rare blood clots after receiving a Johnson and Johnson vaccine.
A patient with blood clots at UCSF is the first case in which a male patient is experiencing rare blood clots after receiving a Johnson and Johnson vaccine.
Smyrna rescinds city's mask mandate
A spokesperson for the city of Smyrna on Monday said a low rate of COVID-19 cases prompted officials to rescind a local executive order requiring masks in the city.
A spokesperson for the city of Smyrna on Monday said a low rate of COVID-19 cases prompted officials to rescind a local executive order requiring masks in the city.
COVID treatment has improved, but many wish for an easy pill
While vaccines are helping to curb the pandemic, easier and better treatments are needed, especially as virus variants spread.
While vaccines are helping to curb the pandemic, easier and better treatments are needed, especially as virus variants spread.
US to share millions of AstraZeneca COVID-19 vaccine doses with world after federal safety review
The White House tells The Associated Press that the U.S. will begin sharing its entire stock of COVID-19 vaccines from AstraZeneca once the vaccine clears federal safety reviews.
The White House tells The Associated Press that the U.S. will begin sharing its entire stock of COVID-19 vaccines from AstraZeneca once the vaccine clears federal safety reviews.
EU launches legal action against COVID-19 vaccine maker AstraZeneca over dose shortage
The European Commission says it’s launched legal action against the COVID-19 vaccine maker AstraZeneca in regards to an untimely delivery of millions of doses.
The European Commission says it’s launched legal action against the COVID-19 vaccine maker AstraZeneca in regards to an untimely delivery of millions of doses.